Skip to main content
. 2019 Feb 15;11:1551–1557. doi: 10.2147/CMAR.S193948

Table 3.

Univariate and multivariate analyses of survival in DEB-TACE group

Variables Categories Univariates Multivariates

Median OS (days) χ2 P HR (95% CI) P-value

Sex Male 346 0.018 0.893
Female 322
Child–Pugh Class A 370 1.536 0.215
B 244
Tumor response PR 534 11.252 0.004 2.051 (1.039–4.047) 0.038
SD 346
PD 240
APS grade 1 425 11.442 0.003 3.101 (1.268–7.587) 0.013
2 346
3 184
Ascites Absence 370 0.805 0.369
Presence 346
PVTT Absence 370 1.916 0.166
Presence 333
ALB >35 322 2.851 0.240
28–35 346
<28 371
Total bilirubin <34 370 11.266 0.001 103.139 (4.658–2283.906) 0.003
34–51 106
ECOG ps 0 389 1.530 0.465
1 322
2 346
Tumor size <50 mm 534 6.227 0.013
≥50 mm 322

Abbreviations: ALB, albumin; APS, arterioportal shunt; DEB-TACE, transarterial chemoembolization with drug-eluting beads; ECOG ps, Eastern Cooperative Oncology Group performance status; OS, overall survival; PD, progression disease; PR, partial response; PVTT, portal venous tumor thrombus; SD, stable disease.